Core Insights - Zoetis reported $2.21 billion in revenue for Q4 2023, an 8.5% year-over-year increase, with EPS of $1.24 compared to $1.15 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $2.19 billion by 1.04%, while EPS fell short of the consensus estimate of $1.33 by 6.77% [1] Revenue Performance - U.S. revenue reached $1.21 billion, surpassing the average estimate of $1.19 billion, reflecting an 8.9% year-over-year increase [2] - Livestock revenue in the U.S. was $270 million, exceeding the estimate of $248.25 million, marking a 4.3% increase year-over-year [2] - International revenue for Companion Animals was $507 million, slightly below the estimate of $510.84 million, but still showing a 12.7% year-over-year growth [2] - Total international revenue was $982 million, above the estimate of $971.31 million, representing a 9% year-over-year increase [2] Segment Performance - Companion Animal revenue totaled $1.45 billion, slightly below the estimate of $1.47 billion, with an 11.1% year-over-year increase [2] - Livestock revenue was $745 million, exceeding the estimate of $696.05 million, reflecting a 4.9% year-over-year increase [2] - Contract Manufacturing & Human Health revenue was $20 million, below the estimate of $25.39 million, showing a significant decline of 25.9% year-over-year [2] - Poultry revenue within Livestock was $127 million, surpassing the estimate of $119.46 million, with a 10.4% year-over-year increase [2] - Companion Animal revenue from Horses was $88 million, exceeding the estimate of $55.62 million, marking an 11.4% year-over-year increase [2] - Revenue from Dogs and Cats was $1.36 billion, below the estimate of $1.44 billion, with an 11.1% year-over-year increase [2] - Swine revenue was $139 million, slightly above the estimate of $132.59 million, reflecting a 0.7% year-over-year increase [2] - Cattle revenue was $401 million, exceeding the estimate of $346.82 million, representing a 6.4% year-over-year increase [2] Stock Performance - Over the past month, Zoetis shares returned -1.1%, while the Zacks S&P 500 composite increased by 5.1% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]
Compared to Estimates, Zoetis (ZTS) Q4 Earnings: A Look at Key Metrics